This opportunity is no longer accepting applications.
grant PAR-22-202

Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)

This grant aims to speed up the development of medications for treating Substance Use Disorders by funding impactful preclinical and clinical research projects. The goal is to move medications closer to FDA approval. Projects are funded for up to 3 years with grants as large as $5 million per year. These projects are closely monitored by NIDA staff and involve significant scientific collaborat…

The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of medication for the treatment of Substance Use Disorders (SUDs) by encouraging research applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medi…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Program: SBIR

Awards & funding

Award Ceiling: $5M
Award Amount: $5M

Dates

Opportunity Released: September 1, 2022
Open for Submission: September 1, 2022
Submission Deadline: September 1, 2025
Application Window Closes: September 1, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.